Non-Current Assets
Other Non-Current Assets
Pfizer Other Non-Current Assets increased by 3.4% to $9.63B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from $9.82B to $9.63B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 16.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
Large fluctuations may relate to changes in long-term investment strategy or tax accounting adjustments.
Detailed definition
A catch-all category for long-term assets that do not fit into major classifications like PPE or Intangibles. This may i...
Peer comparison
Often contains strategic minority investments in technology partners or long-term tax-related items.
Metric ID:
other_non_current_assetsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.06B | $6.71B | $7.68B | $7.88B | $7.66B | $10.89B | $13.16B | $12.97B | $13.03B | $8.81B | $12.47B | $11.20B | $10.71B | $10.49B | $9.82B | $9.85B | $9.46B | $9.32B | $9.63B |
| QoQ Change | — | +10.7% | +14.5% | +2.6% | -2.8% | +42.2% | +20.9% | -1.5% | +0.5% | -32.4% | +41.6% | -10.2% | -4.3% | -2.1% | -6.4% | +0.3% | -4.0% | -1.5% | +3.4% |
| YoY Change | — | — | — | — | +26.5% | +62.4% | +71.4% | +64.6% | +70.1% | -19.1% | -5.3% | -13.6% | -17.8% | +19.1% | -21.3% | -12.1% | -11.7% | -11.1% | -1.9% |
Range$6.06B – $13.16B
CAGR+10.9%
Avg YoY Growth+13.3%
Median YoY Growth-5.3%
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Pfizer's other non-current assets?
- Pfizer (PFE) reported other non-current assets of $9.63B in Q4 2025.
- How has Pfizer's other non-current assets changed year-over-year?
- Pfizer's other non-current assets decreased by 1.9% year-over-year, from $9.82B to $9.63B.
- What is the long-term trend for Pfizer's other non-current assets?
- Over 5 years (2020 to 2025), Pfizer's other non-current assets has grown at a 16.1% compound annual growth rate (CAGR), from $4.57B to $9.63B.
- What does other non-current assets mean?
- Miscellaneous long-term investments and assets that the company plans to hold for more than a year.